|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 66.40 EUR | +0.42% |
|
-5.52% | +6.41% |
| 07-23 | Eurofins Scientific SE, H1 2026 Earnings Call, Jul 23, 2026 | |
| 07-23 | Eurofins Scientific: BioPharma's slowdown raises questions on 2026 organic growth target |  |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| EUROFINS SCIENTIFIC SE | Other Biotechnology & Medical Research | +0.42% | -5.52% | +6.41% | -3.43% | -35.47% | 13.12B |  | | |
- Stock Market
- Stocks
- ERF Stock
- Charts Eurofins Scientific SE
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
